Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and Cyclosporine in Low Risk MDS
NCT00488436Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- May 2002
- Primary completion
- Jun 2007
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin, cyclosporine in myelodysplastic syndrome (MDS), sponsored by Fundación PETHEMA. Started May 2002; status: completed.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00488436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488436.